• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Utilizing Pharmacists to Optimize Medication Management Strategies During the COVID-19 Pandemic.利用药剂师在 COVID-19 大流行期间优化药物管理策略。
J Pharm Pract. 2022 Apr;35(2):184-189. doi: 10.1177/0897190020961655. Epub 2020 Oct 5.
2
Dynamic pharmacy leadership during the COVID-19 crisis: Optimizing patient care through formulary and drug shortage management.在 COVID-19 危机期间的动态药学领导力:通过处方集和药品短缺管理优化患者护理。
Am J Health Syst Pharm. 2020 Oct 30;77(22):1874-1884. doi: 10.1093/ajhp/zxaa219.
3
Perspectives from the frontline: A pharmacy department's response to the COVID-19 pandemic.从一线角度看问题:药房部门应对 COVID-19 大流行的举措。
Am J Health Syst Pharm. 2020 Aug 20;77(17):1409-1416. doi: 10.1093/ajhp/zxaa176.
4
Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.在 COVID-19 大流行期间提供药学服务的建议和指导:中国视角。
Res Social Adm Pharm. 2021 Jan;17(1):1819-1824. doi: 10.1016/j.sapharm.2020.03.012. Epub 2020 Mar 26.
5
Optimal Management of the Public and Patients by Pharmacists in the Era of COVID-19: An Evidence-Based Review and Practical Recommendations.新冠疫情时代药师对公众和患者的最佳管理:基于证据的综述及实用建议
Front Public Health. 2022 Jan 11;9:758325. doi: 10.3389/fpubh.2021.758325. eCollection 2021.
6
Hospital Pharmacist experience in the Intensive Care Unit: Plan COVID.医院药剂师在重症监护病房的经验:“计划新冠”。
Farm Hosp. 2020 Jun 12;44(7):32-35. doi: 10.7399/fh.11510.
7
Post-acute long-term care COVID-19 medication optimization survey: Informing medication management initiatives.新冠疫情后长期护理药物优化调查:为药物管理举措提供信息。
Geriatr Nurs. 2022 Mar-Apr;44:266-271. doi: 10.1016/j.gerinurse.2022.02.001. Epub 2022 Feb 14.
8
Considerations for development of pharmacy support models for COVID-19 alternate care sites.考虑为 COVID-19 备用护理场所开发药剂支持模式。
Am J Health Syst Pharm. 2020 Sep 18;77(19):1592-1597. doi: 10.1093/ajhp/zxaa214.
9
COVID-19 pandemic preparedness: A practical guide from an operational pharmacy perspective.《COVID-19 大流行准备:来自运营药房视角的实用指南》。
Am J Health Syst Pharm. 2020 Sep 18;77(19):1598-1605. doi: 10.1093/ajhp/zxaa212.
10
Hospital Pharmacy in the multidisciplinary team of COVID inpatient units.新冠住院病房多学科团队中的医院药学
Farm Hosp. 2020 Jun 12;44(7):40-42. doi: 10.7399/fh.11517.

引用本文的文献

1
Disruption to diabetes and hypertension care during the COVID-19 pandemic in Latin America and the Caribbean and mitigation approaches: a scoping review.拉丁美洲和加勒比地区2019冠状病毒病大流行期间糖尿病和高血压护理的中断及缓解措施:一项范围综述
BMC Health Serv Res. 2025 May 8;25(1):660. doi: 10.1186/s12913-025-12760-3.
2
Optimization in the Context of COVID-19 Prediction and Control: A Literature Review.新冠疫情预测与防控背景下的优化:文献综述
IEEE Access. 2021 Sep 17;9:130072-130093. doi: 10.1109/ACCESS.2021.3113812. eCollection 2021.
3
Why the Utilization of Ready-to-Administer Syringes During High-Stress Situations Is More Important Than Ever.为什么在高压力情况下使用即用型注射器比以往任何时候都更加重要。
J Infus Nurs. 2022;45(1):27-36. doi: 10.1097/NAN.0000000000000451.
4
COVID the Catalyst for Evolving Professional Role Identity? A Scoping Review of Global Pharmacists' Roles and Services as a Response to the COVID-19 Pandemic.新冠疫情是职业角色认同演变的催化剂?对全球药剂师应对新冠疫情的角色与服务的范围综述
Pharmacy (Basel). 2021 May 4;9(2):99. doi: 10.3390/pharmacy9020099.

本文引用的文献

1
COVID-19 Complicated by Acute Pulmonary Embolism.新型冠状病毒肺炎合并急性肺栓塞
Radiol Cardiothorac Imaging. 2020 Mar 16;2(2):e200067. doi: 10.1148/ryct.2020200067. eCollection 2020 Apr.
2
SARS-CoV-2 outbreak: How can pharmacists help?SARS-CoV-2 爆发:药剂师如何提供帮助?
Res Social Adm Pharm. 2021 Feb;17(2):480-482. doi: 10.1016/j.sapharm.2020.03.018. Epub 2020 Mar 26.
3
Acute pulmonary embolism and COVID-19 pneumonia: a random association?急性肺栓塞与新型冠状病毒肺炎:一种随机关联?
Eur Heart J. 2020 May 14;41(19):1858. doi: 10.1093/eurheartj/ehaa254.
4
Providing pharmacy services during the coronavirus pandemic.在新冠疫情期间提供药学服务。
Int J Clin Pharm. 2020 Apr;42(2):299-304. doi: 10.1007/s11096-020-01017-0. Epub 2020 Mar 28.
5
A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice.一项运用网络分析对“减药”这一新兴定义的系统评价:对未来研究和临床实践的启示
Br J Clin Pharmacol. 2015 Dec;80(6):1254-68. doi: 10.1111/bcp.12732.
6
Reducing inappropriate polypharmacy: the process of deprescribing.减少不适当的多种药物治疗:减药过程。
JAMA Intern Med. 2015 May;175(5):827-34. doi: 10.1001/jamainternmed.2015.0324.
7
Switch over from intravenous to oral therapy: A concise overview.从静脉治疗转换为口服治疗:简要概述。
J Pharmacol Pharmacother. 2014 Apr;5(2):83-7. doi: 10.4103/0976-500X.130042.
8
Deprescribing: what is it and what does the evidence tell us?减药:它是什么,证据又告诉了我们什么?
Can J Hosp Pharm. 2013 May;66(3):201-2. doi: 10.4212/cjhp.v66i3.1261.
9
Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.骨科手术患者静脉血栓栓塞症的预防:抗血栓治疗和血栓预防,第 9 版:美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e278S-e325S. doi: 10.1378/chest.11-2404.
10
Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.非骨科手术患者静脉血栓栓塞症的预防:抗血栓治疗和血栓预防,第 9 版:美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e227S-e277S. doi: 10.1378/chest.11-2297.

利用药剂师在 COVID-19 大流行期间优化药物管理策略。

Utilizing Pharmacists to Optimize Medication Management Strategies During the COVID-19 Pandemic.

机构信息

HCA Holdings Inc, Nashville, TN, USA.

出版信息

J Pharm Pract. 2022 Apr;35(2):184-189. doi: 10.1177/0897190020961655. Epub 2020 Oct 5.

DOI:10.1177/0897190020961655
PMID:33016180
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9086205/
Abstract

As the COVID-19 pandemic swept through the United States, our heath-system mobilized clinical pharmacy services to address critical clinical medication management needs. Reinforcing recommended medication management strategies for clinical pharmacists was key to successful implementation. Best practice strategies include converting patients from intravenous (IV) to oral medication, transitioning to IV push medication administration, evaluating standard medication administration timing, reviewing metered dose inhaler (MDI) and nebulizer utilization, using alternatives for medications in short supply, reviewing coronavirus disease COVID-19 treatment recommendations, reviewing COVID-19 patient care on interdisciplinary rounds, de-prescribing and de-escalating to eliminate unnecessary medications, and assessing for appropriate venous thromboembolism prophylaxis. These strategies served to help protect medication supply, reduce number of staff entries into patient rooms to conserve personal protective equipment, limit nursing time in patient rooms to reduce COVID-19 exposure risk, and to conserve compounding supplies. Here we present example medication management guidance as used by a large healthcare system during the COVID-19 pandemic.

摘要

随着 COVID-19 疫情在美国蔓延,我们的医疗系统调动临床药学服务来满足关键的临床用药管理需求。强化推荐的临床药师用药管理策略是成功实施的关键。最佳实践策略包括将患者从静脉(IV)用药转为口服用药,转为 IV 推注药物管理,评估标准药物给药时间,审查计量吸入器(MDI)和雾化器的使用情况,使用短缺药物的替代品,审查冠状病毒病 COVID-19 治疗建议,在跨学科查房时审查 COVID-19 患者护理,减药和降级以消除不必要的药物,以及评估适当的静脉血栓栓塞预防。这些策略有助于保护药物供应,减少进入患者房间的工作人员数量以节省个人防护设备,限制护士在患者房间的时间以降低 COVID-19 暴露风险,并节省配制用品。在此,我们展示了在 COVID-19 大流行期间,一家大型医疗系统使用的示例药物管理指南。